Salient Capital Advisors’s USA Compression Partners USAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,161
Closed -$351K 30
2022
Q3
$351K Buy
+20,161
New +$356K 0.02% 38
2020
Q1
Sell
-71,370
Closed -$1.29M 68
2019
Q4
$1.29M Sell
71,370
-45,955
-39% -$784K 0.04% 49
2019
Q3
$2.03M Buy
117,325
+17,760
+18% +$301K 0.05% 38
2019
Q2
$1.77M Buy
99,565
+7,121
+8% +$122K 0.04% 45
2019
Q1
$1.44M Sell
92,444
-26,660
-22% -$406K 0.03% 45
2018
Q4
$1.55M Sell
119,104
-4,168
-3% -$62K 0.04% 43
2018
Q3
$2.04M Sell
123,272
-22,336
-15% -$376K 0.04% 46
2018
Q2
$2.45M Buy
+145,608
New +$2.6M 0.05% 53

Other funds holding USAC

Salient Capital Advisors's USAC Position: Q4 2022 in Review

Salient Capital Advisors sold out of USA Compression Partners (USAC) in Q4 2022, closing a stake of 20,161 shares — an estimated $351K sold.

Salient Capital Advisors first reported a position in USAC in Q2 2018 and held it in 8 quarters. The position peaked at $2.45M in Q2 2018. 81 funds tracked by Wall St. Rank hold USAC as of Q4 2022.

  • Salient Capital Advisors reported no remaining USA Compression Partners position as of Q4 2022 after selling out during the quarter.
  • Salient Capital Advisors sold 20,161 USA Compression Partners shares in Q4 2022, an estimated $351K.
  • Salient Capital Advisors first reported a position in USA Compression Partners in Q2 2018 and held it in 8 quarters.
  • Salient Capital Advisors's USA Compression Partners position peaked at $2.45M in Q2 2018.
  • 81 funds tracked by Wall St. Rank held USA Compression Partners as of Q4 2022.

Based on Salient Capital Advisors's 13F filing for Q4 2022.